Topotecan (T) +/- Sorafenib (S) For Platinum-Resistant Ovarian Cancer (Proc): Results Of Doubleblind Placebo-Controlled Randomized Noggo - Ago Intergroup TrialJalid Sehouli,Sven Mahner,Tanja Neunhoeffer,P. Harter,N de Gregorio,Claudius Fridrich,Susanne Markmann,R. Richter,Jochem Potenberg,Ralf Lorenz,Marcus Schmidt,Gabriele Doering,A. Belau,H.-J. Lueck,Radoslav Chekerov,A du Bois,Felix HilpertINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2016)引用 20|浏览35暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络